|
|
|
Insider
Information: |
Sjuts Dustin S |
Relationship: |
President |
City: |
Newark |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
167,550 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$715,439 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
167,550 |
|
|
Total
Value |
$715,439 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Revance Therapeutics, Inc. |
RVNC |
President |
2024-03-18 |
167,550 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2019-12-15 |
4 |
D |
$15.99 |
$9,210 |
D/D |
(576) |
11,492 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial OfficerOffice |
|
2019-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,068 |
|
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2019-12-31 |
4 |
A |
$10.82 |
$4,133 |
D/D |
382 |
13,784 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-04-15 |
4 |
D |
$14.80 |
$6,394 |
D/D |
(432) |
33,064 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-02-15 |
4 |
D |
$25.33 |
$7,295 |
D/D |
(288) |
33,496 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
33,784 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-06-30 |
4 |
A |
$13.80 |
$13,796 |
D/D |
1,000 |
34,064 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-12-15 |
4 |
D |
$26.75 |
$15,034 |
D/D |
(562) |
44,951 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-09-30 |
4 |
D |
$25.14 |
$152,122 |
D/D |
(6,051) |
45,513 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
51,564 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2021-04-15 |
4 |
D |
$28.16 |
$11,574 |
D/D |
(411) |
65,098 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2021-02-15 |
4 |
D |
$28.97 |
$69,818 |
D/D |
(2,410) |
65,509 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2021-06-30 |
4 |
A |
$24.09 |
$21,246 |
D/D |
882 |
65,980 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
Chief Commercial Officer |
|
2021-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,620 |
67,919 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2023-02-15 |
4 |
D |
$33.21 |
$91,859 |
D/D |
(2,766) |
93,046 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2022-12-15 |
4 |
D |
$21.50 |
$62,694 |
D/D |
(2,916) |
95,207 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2022-12-31 |
4 |
A |
$12.18 |
$7,369 |
D/D |
605 |
95,812 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2022-03-15 |
4 |
D |
$15.79 |
$28,975 |
D/D |
(1,835) |
97,123 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2022-06-30 |
4 |
A |
$11.75 |
$11,747 |
D/D |
1,000 |
98,123 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2022-02-15 |
4 |
D |
$13.35 |
$32,427 |
D/D |
(2,429) |
98,958 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2021-12-15 |
4 |
D |
$15.92 |
$8,167 |
D/D |
(513) |
101,387 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2021-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
35,920 |
101,900 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2023-03-15 |
4 |
D |
$30.65 |
$90,939 |
D/D |
(2,967) |
120,967 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2023-03-09 |
4 |
S |
$31.59 |
$679,358 |
D/D |
(21,508) |
123,934 |
0 |
% |
|
RVNC |
Revance Therapeutics, Inc... |
President |
|
2022-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
52,396 |
145,442 |
0 |
- |
|
36 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|